297
Views
14
CrossRef citations to date
0
Altmetric
Review Article

Genetics of platelet traits in ischaemic stroke: focus on mean platelet volume and platelet count

&
Pages 511-522 | Received 04 Jun 2018, Accepted 15 Oct 2018, Published online: 26 Nov 2018

References

  • Arévalo-Lorido JC, Carretero-Gómez J, Álvarez-Oliva A. Mean platelet volume in acute phase of ischemic stroke, as predictor of mortality and functional outcome after 1 year. J Stroke Cerebrovasc Dis. 2013;22:297–303.
  • Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation. 1999;99:999–1004.
  • Longstreth W, Rosendaal F, Siscovick D. Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A). Stroke. 1998;29:577–580.
  • Lalouschek W, Schillinger M, Hsieh K, et al. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years . Stroke. 2005;36:1405–1409.
  • Zenz W, Bodo Z, Plotho J, et al. Factor V Leiden and prothrombin gene G 20210 A variant in children with ischaemic stroke. Thromb Haemost. 1998;80:763–766.
  • McColl M, Chalmers E, Thomas A, et al. Factor V Leiden, prothrombin 20210G > A and the MTHFR C677T mutations in childhood stroke. Thromb Haemost. 1999;81:690–694.
  • Aznar J, Mira Y, Vayá A, et al. Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischaemic stroke. Thromb Haemost. 2004;9205:1031–1034.
  • Pezzini A, Del Zotto E, Magoni M, et al. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke. 2003;34:28–33.
  • Lopaciuk S, Bykowska K, Kwiecinski H, et al. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin Appl Thromb Hemost. 2001;7:346–350.
  • Huttner HB, Schellinger PD, Hartmann M, et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke. 2006;37:1465–1470.
  • Berge E, Haug KBF, Sandset EC, et al. The factor V Leiden, prothrombin gene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ischaemic stroke and atrial fibrillation. Stroke. 2007;38:1069–1071.
  • Reuner KH, Ruf A, Grau A, et al. Prothrombin gene G20210->A transition is a risk factor for cerebral venous thrombosis. Stroke. 1998;29:1765.
  • Roldán V, Marín F, Martínez JG, et al. Relation of interleukin-6 levels and prothrombin fragment 1 + 2 to a point-based score for stroke risk in atrial fibrillation . Am J Cardiol. 2005;95:881–882.
  • Günther G, Junker R, Sträter R, et al. Symptomatic ischemic stroke in full-term neonates : role of acquired and genetic prothrombotic risk factors. Stroke. 2000;31:2437–2441.
  • Huang Y, Zhao YY, Li S. Hyperhomocysteine, methylenetetrahydrofolate reductase gene, and other risk factors in ischaemic stroke. Zhonghua Yi Xue Za Zhi. 2002;822:119–122.
  • Holmes MV, Newcombe P, Hubacek JA, et al. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. The Lancet. 2011;378:584–594.
  • Kelly P, Rosand J, Kistler J, et al. Homocysteine, MTHFR 677C->T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology. 2002;59:529–536.
  • Pezzini A, Del Zotto E, Archetti S, et al. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke. 2002;33:664–669.
  • Cronin S, Furie KL, Kelly PJ. Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke. 2005;36:1581.
  • Casas JP, Bautista LE, Smeeth L, et al. Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet. 2005;365:224–232.
  • Pezzini A, Grassi M, Del Zotto E, et al. Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke. 2007;38:3145–3151.
  • Sazci A, Ergul E, Tuncer N, et al. Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: dual effect of MTHFR polymorphisms C677T and A1298C. Brain Res Bull. 2006;71:45–50.
  • Alluri R, Mohan V, Komandur S, et al. MTHFR C677T gene mutation as a risk factor for arterial stroke: a hospital based study. Eur J Neurol. 2005;12:40–44.
  • Li P, Qin C. Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and susceptibility to ischaemic stroke: a meta-analysis. Gene. 2014;535:359–364.
  • Eikelboom JW, Hankey GJ, Anand SS, et al. Association between high homocyst (e) ine and ischaemic stroke due to large-and small-artery disease but not other etiologic subtypes of ischaemic stroke. Stroke. 2000;31:1069–1075.
  • Sharma P. Meta-analysis of the ACE gene in ischaemic stroke. J Neurol Neurosurg Psychiatry. 1998;64:227–230.
  • Szolnoki Z, Somogyvári F, Kondacs A, et al. Evaluation of the roles of the Leiden V mutation and ACE I/D polymorphism in subtypes of ischaemic stroke. J Neurol. 2001;248:756–761.
  • Munshi A, Sharma V, Kaul S, et al. Association of the -344C/T aldosterone synthase (CYP11B2) gene variant with hypertension and stroke . J Neurol Sci. 2010;296:34–38.
  • Saidi S, Mahjoub T, Almawi WY. Aldosterone synthase gene (CYP11B2) promoter polymorphism as a risk factor for ischaemic stroke in Tunisian Arabs. J Renin Angiotensin Aldosterone Syst. 2010;11:180–186.
  • Avdonina M, Nasedkina T, Ikonnikova A, et al. Association study of polymorphic markers of F12, PON1, PON2, NOS2, PDE4D, HIF1a, GPIba, CYP11B2 genes with ischaemic stroke in Russian patients. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova. 2012;1122:51–54.
  • Yan G, Wang Y. Association of CYP11B2 gene polymorphism with ischemic stroke in the north Chinese Han population. Neurol India. 2012;60:504.
  • Tu Y, Cui G, Xu Y, et al. Genetic polymorphism of CYP11B2 gene and stroke in the Han Chinese population and a meta-analysis. Pharmacogenet Genomics. 2011;21:115–120.
  • Kim SK, Yim S-V, Lee B-C. Association between cytochrome P450 promoter polymorphisms and ischaemic stroke. Exp Ther Med. 2012;3:261–268.
  • Munshi A, Sharma V, Kaul S, et al. Association of 1347 G/A cytochrome P450 4F2 (CYP4F2) gene variant with hypertension and stroke. Mol Biol Rep. 2012;39:1677–1682.
  • Deng S, Zhu G, Liu F, et al. CYP4F2 gene V433M polymorphism is associated with ischemic stroke in the male Northern Chinese Han population. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:664–668.
  • Yi X, Liao D, Fu X, et al. Interaction among CYP2C8, EPHX2, and CYP4A11 gene variants significantly increases the risk for ischemic stroke in Chinese Populations. J Atheroscler Thromb. 2015;22:1148–1157.
  • Cui G, Wang H, Li R, et al. Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke. J Neuroinflammation. 2012;9:235.
  • Gu L, Su L, Wu G, et al. Association between TNF-δ 238G/A polymorphisms and the risk of ischemic stroke. Int J Neurosci. 2013;123:1–6.
  • Cvetkovic JT, Wiklund PG, Ahmed E, et al. Polymorphisms of IL-1beta, IL-1Ra, and TNF-alpha genes: a nested case-control study of their association with risk for stroke . J Stroke Cerebrovasc Dis. 2005;14:29–35.
  • Lõhmussaar E, Gschwendtner A, Mueller JC, et al. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke. 2005;36:731–736.
  • Kuhlenbäumer G, Berger K, Huge A, et al. Evaluation of single nucleotide polymorphisms in the phosphodiesterase 4D gene (PDE4D) and their association with ischaemic stroke in a large German cohort. J Neurol Neurosurg Psychiatry. 2006;774:521–524.
  • Woo D, Kaushal R, Kissela B, et al. Association of Phosphodiesterase 4D with ischemic stroke: a population-based case-control study. Stroke. 2006;37:371–376.
  • Li N, He Z, Xu J, et al. Association of PDE4D and IL-1 gene polymorphism with ischaemic stroke in a Han Chinese population. Brain Res Bull. 2010;81:38–42.
  • Bevan S, Dichgans M, Gschwendtner A, et al. Variation in the PDE4D gene and ischemic stroke risk: a systematic review and meta-analysis on 5200 cases and 6600 controls . Stroke. 2008;39:1966–1971.
  • Staton J, Sayer M, Hankey G, et al. Association between phosphodiesterase 4D gene and ischaemic stroke. J Neurol Neurosurg Psychiatry. 2006;77:1067–1069.
  • Zee RY, Brophy VH, Cheng S, et al. Polymorphisms of the phosphodiesterase 4D, cAMP-specific (PDE4D) gene and risk of ischemic stroke: a prospective, nested case-control evaluation. Stroke. 2006;37:2012–2017.
  • Kaplan RC, Smith NL, Zucker S, et al. Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischaemic stroke, and hemorrhagic stroke. Atherosclerosis. 2008;201:130–137.
  • Munshi A, Rajeshwar K, Kaul S, et al. Association of tumor necrosis factor-α and matrix metalloproteinase-3 gene variants with stroke . Eur J Neurol. 2011;18:1053–1059.
  • Kim SK, Kang SW, Kim DH, et al. Matrix metalloproteinase-3 gene polymorphisms are associated with ischaemic stroke. J Interferon Cytokine Res. 2012;32:81–86.
  • Della-Morte D, Guadagni F, Palmirotta R, et al. Genetics of ischaemic stroke, stroke-related risk factors, stroke precursors and treatments. Pharmacogenomics. 2012;13:595–613.
  • Zhao J, Xu Y, Xing H, et al. Associations between matrix metalloproteinase gene polymorphisms and the development of cerebral infarction. Genet Mol Res. 2016;144:19418–19424.
  • Munshi A, Babu MS, Kaul S, et al. Association of LPL gene variant and LDL, HDL, VLDL cholesterol and triglyceride levels with ischemic stroke and its subtypes. J Neurol Sci. 2012;318:51–54.
  • Morrison AC, Ballantyne CM, Bray M, et al. LPL polymorphism predicts stroke risk in men. Genet Epidemiol. 2002;22:233–242.
  • Spence JD, Ban MR, Hegele RA. Lipoprotein lipase (LPL) gene variation and progression of carotid artery plaque. Stroke. 2003;34:1176–1180.
  • Parfenov MG, Nikolaeva TY, Sudomoina MA, et al. Polymorphism of apolipoprotein E (APOE) and lipoprotein lipase (LPL) genes and ischaemic stroke in individuals of Yakut ethnicity. J Neurol Sci. 2007;255:42–49.
  • Del Zoppo GJ. The role of platelets in ischemic stroke. Neurology. 1998;51: S9–S14.
  • Butterworth RJ, Bath PM. The relationship between mean platelet volume, stroke subtype and clinical outcome. Platelets. 1998;9:359–364.
  • Bath P, Algert C, Chapman N, et al. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke. 2004;35:622–626.
  • Du J, Wang Q, He B, et al. Association of mean platelet volume and platelet count with the development and prognosis of ischaemic and hemorrhagic stroke. Int J Lab Hem. 2016;38:233–239.
  • Shameer K, Denny JC, Ding K, et al. A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects. Hum Genet. 2014;133:95–109.
  • Nadar SK, Lip GY, Blann AD. Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke. The West Birmingham Stroke Project. Thromb Haemost. 2004;92:1342–1348.
  • Bielczyk-Maczyńska E, Serbanovic-Canic J, Ferreira L, et al. A loss of function screen of identified genome-wide association study Loci reveals new genes controlling hematopoiesis. PLoS Genet. 2014;10:e1004450.
  • Panova-Noeva M, Schulz A, Hermanns MI, et al. Sex-specific differences in genetic and nongenetic determinants of mean platelet volume: results from the Gutenberg Health Study. Blood. 2016;127:251–259.
  • Bertin A, Mahaney MC, Cox LA, et al. Quantitative trait loci for peripheral blood cell counts: a study in baboons. Mamm Genome. 2007;18:361–372.
  • Mahaney MC, Brugnara C, Lease LR, et al. Genetic influences on peripheral blood cell counts: a study in baboons. Blood. 2005;106:1210.
  • Eicher JD, Lettre G, Johnson AD. The genetics of platelet count and volume in humans. Platelets. 2017;29:125–130.
  • Meisinger C, Prokisch H, Gieger C, et al. A genome-wide association study identifies three loci associated with mean platelet volume. Am J Hum Genet. 2009;84:66–71.
  • Soranzo N, Spector TD, Mangino M, et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet. 2009;41:1182–1190.
  • Auer PL, Johnsen JM, Johnson AD, et al. Imputation of exome sequence variants into population-based samples and blood-cell-trait-associated loci in African Americans: NHLBI GO Exome Sequencing Project. Am J Hum Genet. 2012;91:794–808.
  • Iotchkova V, Huang J, Morris JA, et al. Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps. Nat Genet. 2016;48:1303–1312.
  • Bauman LE, Almasy L, Blangero J, et al. Fishing for pleiotropic QTLs in a polygenic sea. Ann Hum Genet. 2005;69:590–611.
  • Garner C, Best S, Menzel S, et al. Two candidate genes for low platelet count identified in an Asian Indian kindred by genome-wide linkage analysis: glycoprotein IX and thrombopoietin. Eur J Hum Genet. 2006;14:101–108.
  • Evans DM, Zhu G, Duffy DL, et al. Multivariate QTL linkage analysis suggests a QTL for platelet count on chromosome 19q. Eur J Hum Genet. 2004;12:835–842.
  • Sankaran VG, Orkin SH. Genome-wide association studies of hematologic phenotypes: a window into human hematopoiesis. Curr Opin Genet Dev. 2013;23:339–344.
  • O’malley T, Langhorne P, Elton R, et al. Platelet size in stroke patients. Stroke. 1995;26:995–999.
  • Thompson CB, Jakubowski JA, Quinn PG, et al. Platelet size as a determinant of platelet function. J Lab Clin Med. 1983;101:205–213.
  • Bessman JD, Williams LJ, Gilmer PR. Platelet size in health and hematologic disease. Am J Clin Pathol. 1982;78:150–153.
  • Cameron HA, Phillips R, Ibbotson RM, et al. Platelet size in myocardial infarction. Br Med J (Clin Res Ed). 1983;287:449–451.
  • Martin JF, Kristensen SD, Mathur A, et al. The causal role of megakaryocyte–platelet hyperactivity in acute coronary syndromes. Nat Rev Cardiol. 2012;9:658–670.
  • Kunicki T, Williams S, Salomon D, et al. Genetics of platelet reactivity in normal, healthy individuals. J Thromb Haemost. 2009;7:2116–2122.
  • Lippi G. Genetic and nongenetic determinants of mean platelet volume. Blood. 2016;127:179–180.
  • Slavka G, Perkmann T, Haslacher H, et al. Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease. Arterioscler Thromb Vasc Biol. 2011;31:1215–1218.
  • Mayda-Domaç F, Misirli H, Yilmaz M. Prognostic role of mean platelet volume and platelet count in ischemic and hemorrhagic stroke. J Stroke Cerebrovasc Dis. 2010;19:66–72.
  • Vasquez LJ, Mann AL, Chen L, et al. From GWAS to function: lessons from blood cells. ISBT Sci Ser. 2016;11:211–219.
  • Chu S, Becker R, Berger P, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010;8:148–156.
  • Bunimov N, Fuller N, Hayward CP. Genetic loci associated with platelet traits and platelet disorders. Semin Thromb Hemost. 2013;39:291–305.
  • Soranzo N, Rendon A, Gieger C, et al. A novel variant on chromosome 7q22.3 associated with mean platelet volume, counts, and function. Blood. 2009;113:3831–3837.
  • Neer EJ, Schmidt CJ, Nambudripad R, et al. The ancient regulatory-protein family of WD-repeat proteins. Nature. 1994;371:297–300.
  • Schmidt A, Hall A. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev. 2002;16:1587–1609.
  • Thiesen S, Kübart S, Ropers H-H, et al. Isolation of two novel human RhoGEFs, ARHGEF3 and ARHGEF4, in 3p13-21 and 2q22. Biochem Biophys Res Commun. 2000;273:364–369.
  • Draviam VM, Stegmeier F, Nalepa G, et al. A functional genomic screen identifies a role for TAO1 kinase in spindle-checkpoint signalling. Nat Cell Biol. 2007;9:556–564.
  • Paul DS, Nisbet JP, Yang T-P, et al. Maps of open chromatin guide the functional follow-up of genome-wide association signals: application to hematological traits. PLoS Genet. 2011;7:e1002139.
  • Hawkins PT, Stephens LR. PI3Kgamma is a key regulator of inflammatory responses and cardiovascular homeostasis. Science. 2007;318:64–66.
  • Kamatani Y, Matsuda K, Okada Y, et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet. 2010;42:210–215.
  • Schick UM, Jain D, Hodonsky CJ, et al. Genome-wide association study of platelet count identifies ancestry-specific loci in Hispanic/Latino Americans. Am J Hum Genet. 2016;98:229–242.
  • Reems JA, Wang W, Tsubata K, et al. Dynamin 3 participates in the growth and development of megakaryocytes. Exp Hematol. 2008;36:1714–1727.
  • Ma D, Sun Y, Lin D, et al. CD226 is expressed on the megakaryocytic lineage from hematopoietic stem cells/progenitor cells and involved in its polyploidization. Eur J Haematol. 2005;74:228–240.
  • Kitajima K, Kojima M, Kondo S, et al. A role of jumonji gene in proliferation but not differentiation of megakaryocyte lineage cells. Exp Hematol. 2001;29:507–514.
  • Barclay AN. Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function . Curr Opin Immunol. 2009;21:47–52.
  • Naslavsky N, McKenzie J, Altan-Bonnet N, et al. EHD3 regulates early-endosome-to-Golgi transport and preserves Golgi morphology. J Cell Sci. 2009;122:389–400.
  • Jose'A G, Quiroga T, Martinez-Perez A, et al. Novel loci involved on platelet function and platelet count identified by a genome-wide study performed in children. Haematologica. 2011;96:1335–1343.
  • Li J, Glessner JT, Zhang H, et al. GWAS of blood cell traits identifies novel associated loci and epistatic interactions in Caucasian and African-American children. Hum Mol Genet. 2013;22:1457–1464.
  • Gieger C, Radhakrishnan A, Cvejic A, et al. New gene functions in megakaryopoiesis and platelet formation. Nature. 2011;480:201–208.
  • Nürnberg ST, Rendon A, Smethurst PA, et al. A GWAS sequence variant for platelet volume marks an alternative DNM3 promoter in megakaryocytes near a MEIS1 binding site. Blood. 2012;120:4859–4868.
  • Kim YK, Oh JH, Kim YJ, et al. Influence of genetic variants in EGF and other genes on hematological traits in Korean populations by a genome-wide approach. BioMed Res Int. 2015;2015:1.
  • Eicher JD, Xue L, Ben-Shlomo Y, et al. Replication and hematological characterization of human platelet reactivity genetic associations in men from the Caerphilly Prospective Study (CaPS). J Thromb Thrombolysis. 2016;41:343–350.
  • Oh JH, Kim YK, Moon S, et al. Genome-wide association study identifies candidate loci associated with platelet count in Koreans. Genomics Inform. 2014;12:225–230.
  • Astle WJ, Elding H, Jiang T, et al. The allelic landscape of human blood cell trait variation and links to common complex disease. Cell. 2016;167:1415–1429.e19.
  • Lo KS, Wilson JG, Lange LA, et al. Genetic association analysis highlights new loci that modulate hematological trait variation in Caucasians and African Americans. Hum Genet. 2011;129:307–317.
  • Qayyum R, Snively BM, Ziv E, et al. A meta-analysis and genome-wide association study of platelet count and mean platelet volume in African Americans. PLoS Genet. 2012;8:e1002491.
  • Kosmicki JA, Churchhouse CL, Rivas MA, et al. Discovery of rare variants for complex phenotypes. Hum Genet. 2016;135:625–634.
  • Grove ML, Yu B, Cochran BJ, et al. Best practices and joint calling of the HumanExome BeadChip: the CHARGE Consortium. PLoS One. 2013;8:e68095
  • Polfus LM, Khajuria RK, Schick UM, et al. Whole-exome sequencing identifies loci associated with blood cell traits and reveals a role for alternative GFI1B splice variants in human hematopoiesis. Am J Hum Genet. 2016;99:481–488.
  • Eicher JD, Chami N, Kacprowski T, et al. Platelet-related variants identified by exomechip meta-analysis in 157,293 individuals. Am J Hum Genet. 2016;99:40–55.
  • Simon LM, Chen ES, Edelstein LC, et al. Integrative multi-omic analysis of human platelet eQTLs reveals alternative start site in Mitofusin 2. Am J Hum Genet. 2016;98:883–897.
  • Burley K, Westbury SK, Mumford AD. TUBB1 variants and human platelet traits. Platelets. 2018;29:209–211.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.